2025 Conference programme
Discover the tracks of 2025 edition
Steered by a prestigious Committee, the MedFIT conference programme brings together bright minds to discuss the latest trends in MedTech, Diagnostic and Digital Health, to debate on innovation-driven topics, to foster learning and spark conversations that matter. International experts will address current industry issues related to collaboration, financing, and digital health.
KEYNOTE SESSION
DAY 1 - Tuesday, December 2nd, 2025
Keynote session and speaker to be announced soon!
PLENARY SESSION
DAY 1 - Tuesday, December 2nd, 2025
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
- 10:00 AM
- 11:00 AM
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
Panel discussion
The rise of digital health solutions is shifting healthcare towards a more patient-driven model. From wearable devices to AI-powered diagnostics, individuals and healthcare professionals are gaining insightful information from the monitoring of health parameters in real‐time, leading to better health management. To what extent are B2C approaches gaining interest from the leaders of the sector to complement traditional pathways? How are MedTech and digital health companies adapting their business models to meet individuals’ expectations? Can patients, and more broadly the population, drive innovation through a participatory approach with healthcare professionals and the industry? What regulatory, economic, and ethical challenges come with this shift towards B2C solutions?
- Lynn Coorevits, Digital Health Innovation Manager, imec
TRACK 1 - Fostering collaborative practices
DAY 1 - Tuesday, December 2nd, 2025
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
- 11:30 AM
- 12:30 PM
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
Panel discussion
Spin-offs play a crucial role in translating academic research into real-world solutions, but their success in fulfilling their mission depends on more than just great science. How can academic institutions and tech transfer offices provide the right support to ensure the long-term growth of their spin-offs? What common hurdles do spin-offs face, and how can they be addressed? What are the key ingredients to a synergetic relationship between academia and spin-off? How could incubation and funding models adapt to better serve emerging MedTech and digital health companies?
- Paul Borm, Co-Founder & CTO, Nano4Imaging
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
- 4:15 PM
- 5:00 PM
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
Panel discussion
For start-ups and SMEs, securing a strategic partnership with a large MedTech or health company can be a game-changer, but what exactly are big players looking for? This session will explore how decision makers assess potential collaborations. What are the key factors that make a start-up eye-catching? What common pitfalls can lead to failed partnerships? How can small companies navigate the complexities of working with top industries in the sector?
- Paul Borm, Co-Founder & CTO, Nano4Imaging
DAY 2 - Wednesday, December 3rd, 2025
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
- 2:00 PM
- 3:00 PM
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
Panel discussion
Sustainability has become a priority across industries, the European legislation evolving to answer the matching stakes. For the MedTech sector, it means unique challenges in designing environmentally responsible medical devices. How can companies, regulators, and healthcare providers work together to integrate sustainability into product development? How can public institutions, such as funds, participate in the implementation of sustainability as a compulsory criterion for new technologies?
TRACK 2 - Pre-seed to Series B: On financing innovation
DAY 1 - Tuesday, December 2nd, 2025
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
- 3:00 PM
- 3:45 PM
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
Panel discussion
The boundaries between MedTech, biotech, and digital health are becoming increasingly blurred, with more investors looking at interdisciplinary opportunities. But does this mean MedTech investment is shifting? What types of convergence are investors eyeing? How are investors weighing the risks and analysing the potential for significant returns?
- Kyun Thibaut, Founder & CEO, COVARTIM
DAY 2 - Wednesday, December 3rd, 2025
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
- 9:15 AM
- 10:00 AM
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
Panel discussion
In 2024, Europe attracted a significant increase in funding. Likewise, the MedTech market is driven by strong growth in seed and growth-stage investments, carried by the popularity of AI. As the early-stage investment landscape prospers, how did investors allocate capital in 2025? What trends did we see emerge, and how are they influencing expectations for 2026? This session will provide investors’ perspectives on what’s driving funding decisions up to Series B, which sectors are gaining traction, and how start-ups can position themselves for the coming year.
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
- 10:15 AM
- 11:00 AM
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
Panel discussion
Fundraising is a critical step in the growth of any emerging company, but the path to securing investment is rarely straightforward. CEOs will share their firsthand experiences of raising funds: what strategies proved effective, what challenges they encountered, what they would do differently. How did they engage with investors? What role did strategic partnerships play? And what key lessons can other entrepreneurs take away from their journeys?
- Arezki Yaïche, Head of Coverage France, Mergermarket (ION Group)
TRACK 3 – Digital Health & Medicine innovation
DAY 1 - Tuesday, December 2nd, 2025
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
- 2:00 PM
- 2:45 PM
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
Panel discussion
Despite the growing number of digital health solutions and the positive impact that is expected for healthcare in their implementation, clinical adoption remains a complex and often slow process. What are the key factors that influence whether a digital health product is embraced by healthcare professionals and institutions, as well as by patients? To what extent can successful examples provide a roadmap for others? What are the biggest barriers toward digitalisation and adoption – technological, financial, or cultural – that still need to be addressed?
- Susie A. Ruff, Founder & CEO, RUFF & CO.
DAY 2 - Wednesday, December 3rd, 2025
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
- 11:30 AM
- 12:30 PM
Session that comprises a series of illustrative stories or cases followed by Q&As from the moderator and the audience.
As AI-driven medical technologies are taking root in the healthcare landscape, regulatory frameworks evolve to keep pace. The EU AI Act and MDR introduced new requirements that will shape how AI-powered medical devices are developed, tested, and brought to market. This session will examine the impacts of these new implementations, as well as those we can foresee. How do regulatory bodies and medical devices manufacturers and suppliers face these significant challenges? How are they navigating compliance? How can different stakeholders participate in shaping discussions with regulatory bodies?
- Susie A. Ruff, Founder & CEO, RUFF & CO.
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
- 3:30 PM
- 4:15 PM
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
Panel discussion
Securing reimbursement and navigating market access pathways can be just as critical as regulatory approval for digital health companies. What does it take to make a digital health solution financially viable within healthcare systems? What are the different strategies for start-ups to position themselves on target markets and how to settle on the right fit? What tools and collaborations can start-ups leverage to maximise their chance of success?
Relive the 2024 edition
MedFIT 2024, held on December 3-4 in Lille, brought together global experts to explore trends in MedTech, diagnostics, and digital health. Keynote sessions focused on investment strategies, data-driven medicine, and startup-corporate collaborations. Practical workshops provided insights into market access and regulatory challenges.
As a dynamic platform for fostering innovation and collaboration, MedFIT 2024 played a crucial role in shaping the future of the healthcare industry.
Continue your tour
Contact
Eline Delcroix
- Conference Programme Manager
- edelcroix@eurasante.com
- +33 (0) 978 315 544
